CLSI NBS02-A2
Newborn Screening Follow-up; Approved Guideline – Second Edition, NSB02A2
standard by Clinical and Laboratory Standards Institute, 05/01/2013
Side Navigation
X
CLSI MM23
Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms), 1st Edition, MM23Ed1E
standard by Clinical and Laboratory Standards Institute, 04/01/2015
CLSI MM22-A
Microarrays for Diagnosis and Monitoring of Infectious Diseases; Approved Guideline, MM22AE
standard by Clinical and Laboratory Standards Institute, 02/01/2014
CLSI M26-A
Methods for Determining Bacterial Activity of Antimicrobial Agents; Approved Guideline, M26AE
standard by Clinical and Laboratory Standards Institute, 01/01/1999
CLSI MM20-A (R2018)
Quality Management for Molecular Genetic Testing; Approved Guideline, MM20AE
standard by Clinical and Laboratory Standards Institute, 11/01/2012
CLSI M44-A2
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, M44Ed3E
standard by Clinical and Laboratory Standards Institute, 12/10/2018
CLSI QMS19
Customer Focus in a Quality Management System, 1st Edition, QMS19Ed1E
standard by Clinical and Laboratory Standards Institute, 09/01/2017
CLSI NBS04
Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017
CLSI QMS17
External Assessment, Audits, and Inspections of the Laboratory, 1st Edition, QMS17Ed1E
standard by Clinical and Laboratory Standards Institute, 08/01/2017
CLSI EP12-A2
User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline, Second Edition, EP122A
standard by Clinical and Laboratory Standards Institute, 01/01/2008